Science Explorer Back to mapMap
Discussion

Vtesse (United States)

Research works
1
fractional, all time
Citations
32
33.0 per fractional work
Top-10% rate
11.1%
all institutions 10.0%
Open access
60%
world 40%
International
10%
world 18%

Not ranked overall: Vtesse (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Vtesse (United States) work in?

In all years, 80% of research at Vtesse (United States) is in Health Sciences, 20% in Physical Sciences. Its largest fields are Medicine (70%), Chemistry (10%), Environmental Science (10%).

Physical Sciences20%Health Sciences80%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 4 fields, with their numbers
    1. Medicine170.0%
    2. Health Professions010.0%
    1. Chemistry010.0%
    2. Environmental Science010.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Vtesse (United States)?

The most cited paper from Vtesse (United States) is "Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial" (Daniel S. Ory et al., 2017), with 327 citations. Next come "Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1" (36) and "Phase 1/2 evaluation of intrathecal 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick disease type C1" (5).

Most cited papers
#PaperReleasedCitations
1 Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial Daniel S. Ory et al. · The Lancet Open access 10 Aug 2017 327
2 Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1 Alfred L. Yergey, Paul S. Blank, Stephanie M. Cologna et al. · PLoS ONE Open access 17 Apr 2017 36
3 Phase 1/2 evaluation of intrathecal 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick disease type C1 Forbes D. Porter, Nicole Yanjanin Farhat, Elizabeth A. Ottinger et al. · Molecular Genetics and Metabolism Feb 2016 5
All 3 most cited papers, with filters and sorting

Which research topics does Vtesse (United States) publish most on?

By volume in 2022-now: Animal Ecology and Behavior Studies, Zoonotic diseases and public health, Wildlife Ecology and Conservation and Gastric Cancer Management and Outcomes.

  1. 1 Animal Ecology and Behavior Studies Ecology 0 works
  2. 2 Zoonotic diseases and public health Public Health, Environmental and Occupational Health 0 works
  3. 3 Wildlife Ecology and Conservation Ecology 0 works
  4. 4 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
  5. 5 Pancreatic and Hepatic Oncology Research Oncology 0 works
  6. 6 Colorectal Cancer Treatments and Studies Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available59.6%not open40.4%

World: 40% of research is openly available.

with international co-authors10.3%domestic only89.7%

World: 18% is written across borders.

How has Vtesse (United States)'s research output changed?

still counting20202025

Other research institutions in Gaithersburg

All research institutions in Gaithersburg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Vtesse (United States). Posts are plain text and can be reported.